Abstract
The information about the outcome of primary CNS lymphoma (PCNSL) in India is scarce, because there is no population-based or large hospital-based data. This is a retrospective study that spanned 17 years (2001 to 2017) to study the outcome of PCNSL at the All India Institute of Medical Sciences (AIIMS), which is a tertiary care center in Northern India. Only one of 99 patients was positive for HIV serology. Diffuse large B-cell lymphoma was the most common histology (97.7%). The median patient age was 50 years (range, 13 to 70 years), and the ratio of men to women was 1.9. The median duration of symptoms before diagnosis was 3.5 months (range, 0.5 to 48 months), and 58.5% had a performance status (PS) of 3 or more. Multiple intracranial lesions were present in 81.8% of patients. Surgical resection was performed in 45%, and approximately 22% of patients were ineligible for treatment. Most patients (n = 73) were treated with high-dose methotrexate (HDMTX)-based regimens (ie, methotrexate, vincristine, and procarbazine with or without rituximab). Pharmacokinetic monitoring of methotrexate was not available at our center. HDMTX-related mortality was 3.9%. The median follow-up duration, event-free survival (EFS), and overall surviv...Continue Reading
References
Mar 28, 1998·AIDS·D N LanjewarC R Shetty
Feb 5, 2000·Journal of Neurosurgery·B BatailleF Lapierre
Mar 21, 2002·Surgical Neurology·Manish PowariA K Banerjee
May 30, 2002·Neurology·A J M FerreriJ Y Blay
Nov 27, 2002·Neurology·Rose LaiLisa M DeAngelis
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa M DeAngelisUNKNOWN Radiation Therapy Oncology Group Study 93-10
Jan 12, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M BellinzonaM Saini
Jan 15, 2005·Cancer·Tamara N ShenkierJoseph M Connors
Feb 4, 2005·Journal of Neuro-oncology·Chitra SarkarS K Shankar
Oct 22, 2005·Cancer·Katherine S PanageasLauren E Abrey
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gaurav D ShahLauren E Abrey
Nov 20, 2008·Indian Journal of Cancer·Tr PaulAk Purohit
Sep 22, 2009·Lancet·Andrés J M FerreriUNKNOWN International Extranodal Lymphoma Study Group (IELSG)
Feb 9, 2010·Neurology India·Pankaj A AgarwalB S Singhal
Oct 26, 2010·The Lancet Oncology·Eckhard ThielMichael Weller
Jul 20, 2011·Indian Journal of Cancer·S PasrichaD Patel
Apr 26, 2012·Leukemia & Lymphoma·M JoergerA J M Ferreri
Sep 18, 2012·Neuro-oncology·Michael WellerUNKNOWN German PCNSL Study Group
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick G MorrisAntonio Omuro
Mar 13, 2014·Neurology India·N ManojB A Chandramouli
Jan 2, 2015·Journal of Neurosciences in Rural Practice·Anita MahadevanSusarla Krishna Shankar
Mar 10, 2015·Neurology India·Bimal PatelMazda Turel
Jan 24, 2016·Annals of Hematology·Vanja ZeremskiEnrico Schalk
Mar 29, 2016·British Journal of Haematology·Meredith S ShielsEric A Engels
Apr 19, 2016·Leukemia & Lymphoma·Heidi MocikovaUNKNOWN Czech Lymphoma Study Group
Aug 5, 2016·The Indian Journal of Medical Research·Mehar Chand SharmaVinod Raina
Nov 28, 2016·Hematology/oncology Clinics of North America·Julia Carnevale, James L Rubenstein
May 30, 2017·Cancer Cell·Michail S LionakisWyndham H Wilson
Sep 14, 2017·International Journal of Hematology·Yue SongMingzhi Zhang
Jan 16, 2018·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Chaitanya Krishna PuligundlaLakshmi Srinivas Maddali
Feb 7, 2018·South Asian Journal of Cancer·A H RudreshaL K Rajeev
Apr 11, 2018·Journal of Neuro-oncology·Narayan AdhikariSubhash Chander